KEVLIPAR Trademark

Trademark Overview

On Thursday, January 21, 2016, a trademark application was filed for KEVLIPAR with the United States Patent and Trademark Office. The USPTO has given the KEVLIPAR trademark a serial number of 86882656. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 10, 2020. This trademark is owned by AbbVie Inc.. The KEVLIPAR trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
kevlipar

General Information

Serial Number86882656
Word MarkKEVLIPAR
Filing DateThursday, January 21, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 10, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 17, 2016

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 27, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Monday, February 10, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 10, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 5, 2019EXTENSION 5 GRANTED
Tuesday, July 2, 2019EXTENSION 5 FILED
Friday, July 5, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 2, 2019TEAS EXTENSION RECEIVED
Friday, January 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 9, 2019EXTENSION 4 GRANTED
Wednesday, January 9, 2019EXTENSION 4 FILED
Wednesday, January 9, 2019TEAS EXTENSION RECEIVED
Tuesday, July 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 29, 2018EXTENSION 3 GRANTED
Friday, June 29, 2018EXTENSION 3 FILED
Friday, June 29, 2018TEAS EXTENSION RECEIVED
Thursday, January 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 9, 2018EXTENSION 2 GRANTED
Tuesday, January 9, 2018EXTENSION 2 FILED
Tuesday, January 9, 2018TEAS EXTENSION RECEIVED
Tuesday, June 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 23, 2017EXTENSION 1 GRANTED
Friday, June 23, 2017EXTENSION 1 FILED
Friday, June 23, 2017TEAS EXTENSION RECEIVED
Tuesday, January 10, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2016EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, June 9, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 17, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 17, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 7, 2016ASSIGNED TO EXAMINER
Wednesday, January 27, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 25, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

kevlipar gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related